3675
-
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Real benefits for authors, including fast-track processing of papers.
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
(94,870) Views
Editor in Chief Professor Steven V Edelman
1178-7007(R)
Amantadine reduces glucagon and enhances insulin secretion throughout the oral glucose tolerance test: central plus peripheral nervous system mechanismsFuad Lechin, Bertha van der Dijs, Betty Pardey-Maldonado, et al
Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy
Amy Fleischman, Erinn T Rhodes
Impact of obesity and type 2 diabetes on health-related quality of life in the general population in England
Stephen CL Gough, Nana Kragh, Uffe Jon Ploug, et al
Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials
Jørn Ditzel, Hans Henrik Lervang
Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes
Cyrus V Desouza, Lindsey Rentschler, Vivian Fonseca
Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
Nanne Kleefstra, Johanna Hortensius, Kornelis JJ van Hateren, et al
Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism
Mauro AM Carai, Noemi Fantini, Barbara Loi, et al
Recent results of exenatide use as adjunctive therapy in the treatment of patients with type 2 diabetes
Peggy Soule Odegard, Anthony DeSantis
Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
Jonathan K Reynolds
Alogliptin: a new addition to the class of DPP-4 inhibitors
Radha Andukuri, Andjela Drincic, Marc Rendell
Insulin glulisine in the management of diabetes
Satoru Yamada
Risk management in the treatment of type 2 diabetes with pioglitazone
Giuseppe Derosa, Sibilla AT Salvadeo
Fixed combination of repaglinide and metformin in the management of type 2 diabetes
Robert Moses
p38 MAPK inhibition reduces diabetes-induced impairment of wound healing
Satyanarayana Medicherla, Scott Wadsworth, Breda Cullen, Derek Silcock, et al.
Management of gestational diabetes mellitus
Annunziata Lapolla, Maria Grazia Dalfrà, Domenico Fedele
Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes
Galina Smushkin, Adrian Vella
Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
Paul Valensi
Role and development of GLP-1 receptor agonists in the management of diabetes
Chee W Chia, Josephine M Egan
Analog insulin detemir for patients with type 1 and type 2 diabetes: a review
Gregory E Peterson
Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
Shannon A Miller, Erin L St Onge, J Roger Accardi
Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam – a clinical perspective
Ronald B Goldberg
Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design
Thomas Strack, Luc Martinez, Stefano Del Prato, Larry Blonde, Burkhard Göke, et al
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
